277 related articles for article (PubMed ID: 18768390)
41. Enrichment of atypical hyperdiploidy and IKZF1 deletions detected by SNP-microarray in high-risk Australian AIEOP-BFM B-cell acute lymphoblastic leukaemia cohort.
Berry NK; Scott RJ; Sutton R; Law T; Trahair TN; Dalla-Pozza L; Ritchie P; Barbaric D; Enjeti AK
Cancer Genet; 2020 Apr; 242():8-14. PubMed ID: 32058318
[TBL] [Abstract][Full Text] [Related]
42. Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
Marke R; Havinga J; Cloos J; Demkes M; Poelmans G; Yuniati L; van Ingen Schenau D; Sonneveld E; Waanders E; Pieters R; Kuiper RP; Hoogerbrugge PM; Kaspers GJ; van Leeuwen FN; Scheijen B
Leukemia; 2016 Jul; 30(7):1599-603. PubMed ID: 26713593
[No Abstract] [Full Text] [Related]
43. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.
Han BW; Feng DD; Li ZG; Luo XQ; Zhang H; Li XJ; Zhang XJ; Zheng LL; Zeng CW; Lin KY; Zhang P; Xu L; Chen YQ
Hum Mol Genet; 2011 Dec; 20(24):4903-15. PubMed ID: 21926415
[TBL] [Abstract][Full Text] [Related]
44. Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1.
Olsson L; Albitar F; Castor A; Behrendtz M; Biloglav A; Paulsson K; Johansson B
Genes Chromosomes Cancer; 2015 May; 54(5):315-25. PubMed ID: 25727050
[TBL] [Abstract][Full Text] [Related]
45. RAS pathway mutation is an added-value biomarker in pediatric Philadelphia-negative B-cell acute lymphoblastic leukemia with IKZF1 deletions.
Huang YJ; Liu HC; Jaing TH; Wu KH; Wang SC; Yen HJ; Hsiao CC; Chen SH; Lin PC; Yeh TC; Sheen JM; Chen YC; Chang TK; Huang FL; Chao YH; Hou JY; Yang CP; Lin TH; Shih LY
Pediatr Blood Cancer; 2021 Apr; 68(4):e28899. PubMed ID: 33522704
[TBL] [Abstract][Full Text] [Related]
46. Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia.
Gupta SK; Bakhshi S; Kumar L; Kamal VK; Kumar R
Leuk Lymphoma; 2017 Feb; 58(2):333-342. PubMed ID: 27339065
[TBL] [Abstract][Full Text] [Related]
47. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
[TBL] [Abstract][Full Text] [Related]
48. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
49. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia.
Poulard C; Kim HN; Fang M; Kruth K; Gagnieux C; Gerke DS; Bhojwani D; Kim YM; Kampmann M; Stallcup MR; Pufall MA
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3052-3061. PubMed ID: 30733284
[TBL] [Abstract][Full Text] [Related]
50. CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.
Dworzak MN; Schumich A; Printz D; Pötschger U; Husak Z; Attarbaschi A; Basso G; Gaipa G; Ratei R; Mann G; Gadner H
Blood; 2008 Nov; 112(10):3982-8. PubMed ID: 18780832
[TBL] [Abstract][Full Text] [Related]
51. High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction.
Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
Leuk Res; 2018 Mar; 66():79-84. PubMed ID: 29407587
[TBL] [Abstract][Full Text] [Related]
52. Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols.
Ofverholm I; Tran AN; Heyman M; Zachariadis V; Nordenskjöld M; Nordgren A; Barbany G
Leukemia; 2013 Sep; 27(9):1936-9. PubMed ID: 23538749
[No Abstract] [Full Text] [Related]
53. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
[TBL] [Abstract][Full Text] [Related]
54. IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.
Clappier E; Grardel N; Bakkus M; Rapion J; De Moerloose B; Kastner P; Caye A; Vivent J; Costa V; Ferster A; Lutz P; Mazingue F; Millot F; Plantaz D; Plat G; Plouvier E; Poirée M; Sirvent N; Uyttebroeck A; Yakouben K; Girard S; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
Leukemia; 2015 Nov; 29(11):2154-61. PubMed ID: 26050650
[TBL] [Abstract][Full Text] [Related]
55. Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases.
Bhatia P; Singh M; Singh A; Sharma P; Trehan A; Varma N
Int J Lab Hematol; 2021 Oct; 43(5):1016-1023. PubMed ID: 33538126
[TBL] [Abstract][Full Text] [Related]
56. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.
Evensen NA; Madhusoodhan PP; Meyer J; Saliba J; Chowdhury A; Araten DJ; Nersting J; Bhatla T; Vincent TL; Teachey D; Hunger SP; Yang J; Schmiegelow K; Carroll WL
Haematologica; 2018 May; 103(5):830-839. PubMed ID: 29449434
[TBL] [Abstract][Full Text] [Related]
57. Copy Number Alterations are Associated with the Risk of Very Early Relapse in Pediatric B-lineage Acute Lymphoblastic Leukemia: A Nested Case-control MIGICCL Study.
Rosales-Rodríguez B; Núñez-Enríquez JC; Velázquez-Wong AC; González-Torres C; Gaytán-Cervantes J; Jiménez-Hernández E; Martín-Trejo JA; Campo-Martínez MLÁD; Medina-Sanson A; Flores-Lujano J; Flores-Villegas LV; Peñaloza-González JG; Torres-Nava JR; Espinosa-Elizondo RM; Amador-Sánchez R; Miranda-Madrazo MR; Santillán-Juárez JD; Pérez-Saldívar ML; Gurrola-Silva A; Orozco-Ruiz D; Solís-Labastida KA; Velázquez-Aviña MM; Duarte-Rodríguez DA; Mata-Rocha M; Sepúlveda-Robles OA; Ortiz-Maganda M; Bekker-Méndez VC; Jiménez-Morales S; Mejía-Aranguré JM; Rosas-Vargas H
Arch Med Res; 2021 May; 52(4):414-422. PubMed ID: 33541741
[TBL] [Abstract][Full Text] [Related]
58.
Xu H; Zhao X; Bhojwani D; E S; Goodings C; Zhang H; Seibel NL; Yang W; Li C; Carroll WL; Evans WE; Yang JJ
Clin Cancer Res; 2020 Jan; 26(1):256-264. PubMed ID: 31573954
[TBL] [Abstract][Full Text] [Related]
59. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.
Irving JA; Enshaei A; Parker CA; Sutton R; Kuiper RP; Erhorn A; Minto L; Venn NC; Law T; Yu J; Schwab C; Davies R; Matheson E; Davies A; Sonneveld E; den Boer ML; Love SB; Harrison CJ; Hoogerbrugge PM; Revesz T; Saha V; Moorman AV
Blood; 2016 Aug; 128(7):911-22. PubMed ID: 27229005
[TBL] [Abstract][Full Text] [Related]
60. Frequency of copy number abnormalities in common genes associated with B-cell precursor acute lymphoblastic leukemia cytogenetic subtypes in Brazilian children.
Barbosa TC; Terra-Granado E; Quezado Magalhães IM; Neves GR; Gadelha A; Guedes Filho GE; Souza MS; Melaragno R; Emerenciano M; Pombo-de-Oliveira MS
Cancer Genet; 2015 Oct; 208(10):492-501. PubMed ID: 26277549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
